In November 2025, a batch of dental implant-specific titanium rods, independently declared by YIWU YITECH TRADING CO., LTD., successfully arrived at the Port of Barcelona, Spain, marking the company's official entry into the EU's high-end medical metal supply chain.
The world of Dental Medicine Implantation is an ever-growing field, and Yiwu Yitech appears to understand the high levels of safety, biocompatibility and precision of working with the Implant Materials. With more and more demand, biocompatibility, and corrosion Resistance, Titanium and Titanium alloys have become the Core Materials for Dental Implants. Yitech understands the demand in the potential market and has a business model to easily integrate domestic high-grade Titanium material. The business focuses on providing Medical Grade Titanium rods with Medical Grade Titanium rods with Medical Grade Titanium rods.
All exported titanium rods comply with the pertinent medical device material specifications of having pure chemicals, homogeneous microstructures, and exact dimensional tolerances, and satisfy all the reasonable expectations of downstream manufacturers that require them for extensive processing of implants via turning and grinding, including the complex deep processing techniques. The company team's cooperation with the Spanish client was integral to ensuring the efficacy and seamless functioning of the entire supply chain, and included a joint effort in order processing, quality assurance, and logistics and customs clearance activities.
This successful cooperation can be recognised thanks to Yitech's unparalleled professional expertise and renown in the industrial raw material export domain. Quality assurance from this company has always included the provision of specialised integrated supply chain services with detailed after-sales customer support, which has fostered overseas client loyalty to this company. The successful fulfilment of this order will further allow for expansion into other high-value medical markets in the EU and other countries, due to the fact that Spain represents the EU's prime medical market, and the company's established reputation.
